Prevent preclinical drug base IDIQ.
Ended Awarded Last action
- Contract number
- 75N91019D00016
- Awardee
-
University Of Illinois UEI W8XEAJDKMXH3 Part of University Of Illinois
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $1,683,323 obligated
Award facts
- Opportunity
-
- PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Biomarker Endpoints, Preclinical Services for Biopharmaceutical Product Development and Manufacturing, and Toxicology and Pharmacology Testing Pre-Solicitation · N01CN7701918 · Posted Apr 19, 2018
- PREVENT Cancer Preclinical Drug Development Program Award Notice · Posted May 7, 2018
- Combined order value
- $1,683,323 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 2% used
- $74,995,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The University of Illinois, doing business as The Board of Trustees of the University of Illinois, has been awarded an Indefinite Delivery Contract (IDC) from the National Cancer Institute (NCI), a part of the U.S. Department of Health and Human Services, to support the PREVENT Cancer Preclinical Drug Development Program. This multiple-award IDC, valued at up to $149,995,000, aims to provide a structured approach to the development of cancer drugs and vaccines from discovery through clinical trials. The contract includes three separate pools: evaluating the efficacy and biomarkers of cancer prevention regimens, preclinical product development and Good Manufacturing Practice manufacturing support for candidate cancer prevention vaccines, and assessing the pharmacological and toxicological effects of preventative agents.
Under this IDC, the University of Illinois has been awarded a firm fixed price delivery order worth $1,683,454 to use carnosic acid and vivox40 to assess their preclinical efficacy and intermediate biomarker endpoints for breast cancer prevention. This task order is part of NCI's broader PREVENT program and has no set-aside designation. The work will be performed in Chicago, Illinois, and the period of performance runs through June 2025.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Prevent preclinical efficacy and intermediate biomarker endpoints task order: use of carnosic acid and VIVOX40 for… | National Cancer Institute (NIH) | $1,683,323 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N91019D00016?
75N91019D00016 was awarded to University Of Illinois by National Cancer Institute (National Institutes of Health) on January 24, 2019.
How much is contract 75N91019D00016 worth?
Orders under 75N91019D00016 have obligated $1,683,323. 75N91019D00016's own ceiling is $74,995,000.
How many orders have been placed under contract 75N91019D00016?
1 order has been placed under 75N91019D00016, the latest on July 1, 2020.
Who can order from contract 75N91019D00016?
75N91019D00016 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N91019D00016 part of a contract vehicle?
Yes. 75N91019D00016 is part of PREVENT Preclinical Drug Development Program (PREVENT).
Was contract 75N91019D00016 competed?
The extent of competition for 75N91019D00016 was full and open competition. The government received 9 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV